Application of tanshinone IIA derivative in preparation of ischemic stroke drugs
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2019-06-21
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine, in particular to the application of a tanshinone IIA derivative in the preparation of ischemic stroke medicine, and the compound has a protective effect on cerebral ischemia-reperfusion injury. Background technique
[0002] In recent years, with the acceleration of the aging population in my country, the incidence of cerebrovascular diseases has been increasing year by year. The vast majority of cerebrovascular diseases are strokes caused by ischemia, which seriously endanger human health. At present, the main clinical treatment principles for ischemic stroke are: timely restore the blood flow and reperfusion of blood vessels, improve the blood circulation of the brain, and increase the supply of blood and oxygen in the ischemic area. The main purpose is to save the ischemic penumbra The surviving neurons in the zone reduce the size of the cerebral infarction. (Appelboom G, Strozyk D, Meyers PM, Higashi...